Literature DB >> 35859165

Neutrophil-to-lymphocyte ratio as a predictor for cardiovascular diseases: a cohort study in Tianjin, China.

Yuxin Zhao1,2, Shuaixiang Zhang1,2, Yue Yi1,2, Ting Qu1,2, Si Gao1,2, Yizhou Lin1,2, Hong Zhu3,4.   

Abstract

Based on a cohort in Tianjin, China, we explore the relationship between neutrophils-to-lymphocyte ratio (NLR) and the risk of cardiovascular diseases (CVDs). From January 2010 to December 2019, 4667 eligible participants aged more than 40 years old, CVDs-free, and registered in two community health service centers were recruited and followed up. The values of NLR collected at baseline were included in Cox proportional hazards model to evaluate its association with the incidence risk of CVDs. Hazard ratio (HR) and 95% confidence interval (CI) were calculated before and after adjustment for potential confounding factors selected by LASSO regression. During a total of 13,691 person-years of follow-up among all participants (median, 2.0 years; interquartile range, 1.7-2.5), 150 (3.42%) newly diagnosed CVDs events occurred, with the incidence density of CVDs of 10.96/1000 person-year. The incidence density in subgroups categorized by tertiles of baseline NLR was 8.08/1000, 11.74/1000, and 13.24/1000, respectively (p trend = 0.019). COX models revealed that after adjustment for potential confounders, NLR (as a continuous variable) was significantly related to the risk of total CVDs (HR 1.10, 95% CI: 1.04, 1.17), myocardial infarction (HR 1.12, 95% CI: 1.05, 1.20), and ischemic stroke (HR 1.21, 95% CI: 1.10, 1.33). When NLR was categorized into tertiles, participants in the top tertile had a significantly higher risk of CVDs (HR 1.61, 95% CI: 1.06, 2.44) and myocardial infarction (HR 1.88, 95% CI: 1.09, 3.27) relative to those in the bottom tertile.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35859165     DOI: 10.1038/s41371-022-00724-7

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   2.877


  40 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies.

Authors:  Xiaoding Wang; Guangyu Zhang; Xuejun Jiang; Hongling Zhu; Zhao Lu; Lin Xu
Journal:  Atherosclerosis       Date:  2014-03-14       Impact factor: 5.162

3.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation--performance and standardization: a background paper.

Authors:  William L Roberts
Journal:  Circulation       Date:  2004-12-21       Impact factor: 29.690

Review 4.  Inflammatory biomarkers for predicting cardiovascular disease.

Authors:  Lee Stoner; Adam A Lucero; Barry R Palmer; Lynnette M Jones; Joanna M Young; James Faulkner
Journal:  Clin Biochem       Date:  2013-06-10       Impact factor: 3.281

5.  High Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with Symptomatic Internal Carotid Artery Stenosis.

Authors:  Nicolas Massiot; Fabien Lareyre; Audrey Voury-Pons; Yann Pelletier; Julien Chikande; Joseph Carboni; Emilien Umbdenstock; Elixène Jean-Baptiste; Réda Hassen-Khodja; Juliette Raffort
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-09-27       Impact factor: 2.136

Review 6.  Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects.

Authors:  Luigina Guasti; Francesco Dentali; Luana Castiglioni; Lorenzo Maroni; Franca Marino; Alessandro Squizzato; Walter Ageno; Monica Gianni; Giovanni Gaudio; Anna M Grandi; Marco Cosentino; Achille Venco
Journal:  Thromb Haemost       Date:  2011-08-25       Impact factor: 5.249

Review 7.  Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update.

Authors:  Maxwell E Afari; Tariq Bhat
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-03-04

8.  Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant.

Authors:  Stephanie Kim; Melissa Eliot; Devin C Koestler; Wen-Chih Wu; Karl T Kelsey
Journal:  JAMA Cardiol       Date:  2018-06-01       Impact factor: 14.676

9.  Neutrophil to lymphocyte ratio predicts poor functional capacity in patients with heart failure.

Authors:  Musa Cakıcı; Mustafa Cetin; Adnan Doğan; Muhammed Oylumlu; Erdal Aktürk; Mustafa Polat; Arif Suner; Sabri Abuş
Journal:  Turk Kardiyol Dern Ars       Date:  2014-10

Review 10.  The Link Between Inflammatory Disorders and Coronary Heart Disease: a Look at Recent Studies and Novel Drugs in Development.

Authors:  H Teague; Nehal N Mehta
Journal:  Curr Atheroscler Rep       Date:  2016-01       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.